# Neurolens Convergence Insufficiency Study

> **NCT05087563** · NA · TERMINATED · sponsor: **Neurolens Inc.** · enrollment: 50 (actual)

## Conditions studied

- Binocular Vision Disorder
- Convergence Insufficiency
- Computer Vision Syndrome

## Interventions

- **DEVICE:** Neurolens spectacle lens
- **DEVICE:** Placebo spectacle lens

## Key facts

- **NCT ID:** NCT05087563
- **Lead sponsor:** Neurolens Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-11-22
- **Primary completion:** 2022-05-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** New evidence warranted a change in the study design and study population group (inclusion/ exclusion criterion). We completed another clinical trial focused on subjects with headache symptoms but this particular clinical trial was terminated.
- **Last updated:** 2023-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05087563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05087563, "Neurolens Convergence Insufficiency Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05087563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*